New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 12, 2019 - Mylan launched Wixela™ Inhub™, an AB-rated generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate/salmeterol) inhalation powder.
Download PDF
Return to publications